Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dawnandrew100
    Junior Member
    • Aug 2025
    • 3

    #1

    Introduction

    Hi everyone! I'm Andrew. I currently work as a Medical Laboratory Scientist/EMT but I'm also a PhD student studying bioinformatics and computational biology. I'm still relatively new to the field of bioinformatics but I appreciate all the knowledge I've gained so far. Over the past year, I've been able to start a few open source projects over on GitHub that I'm pretty proud of and I have lots of ambitions to do even more. One of my future projects will be a generalized PBPK/PBPD model that is a part of a simulation that can simulate the body's response to a drug as well as estimate the clearance time for the drug compared to a healthy digital twin simulation. The goal will be to take any arbitrary drug and disease state and run the simulation to get plausible results.

    I'm happy to be here and hope to meet other like-minded individuals!
  • seqadmin
    Senior Member
    • Oct 2022
    • 729

    #2
    Welcome to SEQanswers, Andrew! It’s great to have you here. Your background and projects sound really exciting. We're looking forward to seeing your contributions and discussions as you continue your work in bioinformatics.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...